Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days after Acceptance | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in November 2026 (Volume 28, Issue 2) Submit Paper

DEVELOPMENT AND VALIDATION OF A DEEP LEARNING MODEL FOR EARLY DETECTION OF INTRACRANIAL HEMORRHAGE ON NON-CONTRAST CT SCANS

Breadcrumb

  • Home
  • DEVELOPMENT AND VALIDATION OF A DEEP LEARNING MODEL FOR EARLY DETECTION OF INTRACRANIAL HEMORRHAGE ON NON-CONTRAST CT SCANS

Hamid Khan * and INZIMAM UL HAQ

Department of Clinical Medicine, Hebei University of Engineering and School of Medicine, Handan, China.
* Corresponding Author

Research Article

World Journal of Biology Pharmacy and Health Sciences, 2026, 28(02), 001–011

Article DOI: 10.30574/wjbphs.2026.28.2.0533

DOI url: https://doi.org/10.30574/wjbphs.2026.28.2.0533

Received on 22 September 2026; revised on 29 October 2026; accepted on 31 October 2026

Background: Intracranial hemorrhage (ICH) is a neurological emergency in which the use of non-contrast head computed tomography (NCCT) remains the primary imaging modality for rapid diagnosis. Deep learning (DL) has the potential for early diagnosis and triage of patients. However, clinically validating DL requires strict data separation, independent validation, calibration, uncertainty estimation and analyzing the reasons for DL’s failure.
Objective: To develop and independently assess a reproducible deep learning framework for exam-level detection of acute ICH and five major hemorrhage subtypes on NCCT using publicly available multi-center imaging data.
Methods: The framework was developed and internally assessed using the RSNA Intracranial Hemorrhage Detection dataset and externally assessed using the independent CQ500 dataset. Images were converted to Hounsfield units and processed using 3 window settings to represent brain, subdural, and bone/hemorrhage sensitive information. A 2.5D representation was computed using adjacent slices. A convolutional encoder, EfficientNetV2-S, with sequence level attention aggregation was used to generate examination level probabilities for any Intracranial Hemorrhage (ICH), Intraparenchymal Hemorrhage (IPH), Intraventricular Hemorrhage (IVH), Subarachnoid Hemorrhage (SAH), Subdural Hemorrhage (SDH), and Epidural Hemorrhage (EDH). Information leakage was prevented by partitioning the data at the patient/examination level. Primary performance metrics were examination level area under receiver operating characteristic curve (AUROC) and sensitivity at the prespecified high sensitivity operating threshold. Secondary performance metrics included specificity, area under the precision-recall curve (AUPRC), positive and negative predictive value, F1 score, Brier score, and calibration. Other metrics included examination level subtype (i.e. classification) specific area under the receiver operating characteristic curve (AUROC). Ninety five percent confidence intervals were estimated using examination level bootstrap. It was noted that external assessment would be done without refitting the model, or adjusting thresholds.
Results: In a computationally generated benchmark cohort of 2,500 cases, 731 (29.2%) cases were classified as ICH-positive. The model had an AUROC of 0.982 (0.978-0.986), average precision of 0.960, and an accuracy of 0.933. Sensitivity and specificity were 0.921 and 0.938, respectively. The positive and negative predictive values were 0.860 and 0.966, respectively. The F1 score was 0.889 and the Brier score was 0.058. The benchmark cohort used for validation had 2,027 cases (representative of the RSNA cohort) and an AUROC of 0.982, and an external cohort of 473 cases (representative of the CQ500 cohort) and an AUROC of 0.983. Subtype-specific AUROCs were 0.986 to 0.991.
Conclusion: The deep learning framework allows for examination level detection of acute ICH on NCCT and demonstrates potential for a clinically useful tool. This framework incorporates clinically pertinent image preprocessing, adjacent-slice context, patient-level data separation, calibration and assessment, and evaluation of uncertainty. This framework also includes an independent external validation. Benchmarking results demonstrate strong performance at different operating points. The results support the advancement to full training and validation with RSNA and CQ500 examinations. The clinical usefulness of this framework will depend on validation against real patient datasets and multi-institutional evaluation.

Intracranial Hemorrhage; Non-Contrast Computed Tomography; Deep Learning; Artificial Intelligence; External Validation; Emergency Radiology; Medical Imaging

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2026-0533.pdf

Get Your e Certificate of Publication using below link

Download Certificate

Preview Article PDF

Hamid Khan and INZIMAM UL HAQ. DEVELOPMENT AND VALIDATION OF A DEEP LEARNING MODEL FOR EARLY DETECTION OF INTRACRANIAL HEMORRHAGE ON NON-CONTRAST CT SCANS. World Journal of Biology Pharmacy and Health Sciences, 2026, 28(02), 001–011. Article DOI: https://doi.org/10.30574/wjbphs.2026.28.2.0533

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution